Literature DB >> 30205981

Exploring the patient experience of digital ulcers in systemic sclerosis.

Michael Hughes1, John D Pauling2.   

Abstract

Digital ulcers are common in patients with systemic sclerosis, affecting over half of patients during the course of their disease. For some patients, digital ulcers occur as isolated phenomena; whereas, for others, digital ulceration is recurrent, and often refractory to intervention. Demonstrating treatment efficacy for digital ulcer disease has typically focussed on clinician opinion of ulcer healing and new ulcer occurrence. Advances in management have improved outcomes which may have had the unfortunate effect of rendering traditional trial endpoints less effective at demonstrating treatment efficacy. Despite recent improvements in management, our work is not complete and digital ulceration remains a major cause of morbidity for many patients with systemic sclerosis. This review shall examine the patient experience of digital ulcers in systemic sclerosis. We shall consider how a detailed understanding of the severity and burden of digital ulceration, aetiopathogenesis, and their impact on emotional health, function, work and social participation might inform the development of novel clinical trial outcomes that can support future advances in the assessment and management of digital ulceration in systemic sclerosis.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Digital ulcers; Disability; Function; Health-related quality of life; Impact; Patient experience; Physical symptoms; Systemic sclerosis

Mesh:

Year:  2018        PMID: 30205981     DOI: 10.1016/j.semarthrit.2018.08.001

Source DB:  PubMed          Journal:  Semin Arthritis Rheum        ISSN: 0049-0172            Impact factor:   5.532


  3 in total

Review 1.  Patient-reported outcome instruments in clinical trials of systemic sclerosis.

Authors:  John D Pauling; Joana Caetano; Corrado Campochiaro; Giacomo De Luca; Ana Maria Gheorghiu; Maria Grazia Lazzaroni; Dinesh Khanna
Journal:  J Scleroderma Relat Disord       Date:  2019-11-25

2.  A multicenter randomized, double-blind, placebo-controlled pilot study to assess the efficacy and safety of riociguat in systemic sclerosis-associated digital ulcers.

Authors:  Vivek Nagaraja; Cathie Spino; Erica Bush; Pei-Suen Tsou; Robyn T Domsic; Robert Lafyatis; Tracy Frech; Jessica K Gordon; Virginia D Steen; Dinesh Khanna
Journal:  Arthritis Res Ther       Date:  2019-09-03       Impact factor: 5.156

3.  What narrative devices do people with systemic sclerosis use to describe the experience of pain from digital ulcers: a multicentre focus group study at UK scleroderma centres.

Authors:  Jennifer Jones; Michael Hughes; John Pauling; Rachael Gooberman-Hill; Andrew J Moore
Journal:  BMJ Open       Date:  2020-06-11       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.